Join us for an interactive event focused on Model-Informed Drug Development (MIDD). This event brings together drug development experts in Pharmacometrics, Quantitative Systems Pharmacology (QSP), Clinical Pharmacology, and Physiologically-Based Pharmacokinetic (PBPK) modeling to present the current MIDD landscape, regulatory initiatives, and trends.
Following the presentations, we’ll open the floor for a Q&A session. We invite our audience to bring questions and ask our panel of experts anything—from basic concepts to the latest innovations.
Example questions/topics for discussion:
- Have you seen examples where your model predictions are being validated in the clinic?
- How can MIDD help with drug repurposing?
- How does MIDD support regulatory initiatives such as Project Optimus, reductions in animal studies, or Diversity Action Plans?
- How can MIDD help with novel modalities?
- How can MIDD support technology platforms?
Don’t miss this chance to connect with experts and network with peers. お申込みはこちら
Agenda:
- 5:30-6:00pm – Registration
- 6:00-6:10pm – Introduction by Tong Zhu, PhD, VP, Global Head, Clinical Pharmacology and Translational Medicine
- 6:10-6:20pm – PBPK presented by Hannah Jones, PhD, SVP, Simcyp PBPK Modeling Services
- 6:20-6:30pm – QSP presented by Piet van der Graaf, PharmD, PhD, SVP, Head of QSP
- 6:30-6:40pm – Pharmacometrics presented by Mirjam Trame, PharmD, PhD, VP, Certara Drug Development Solutions, Pharmacometrics Lead, US
- 6:40-7:00pm – Q&A session
- 7:00-8:00pm – Networking reception
会場:
CIC Cambridge – One Broadway, Cambridge, MA 02142